PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Apr-2025 Russell Abberley confirmed as ABPI President-elect ABPI
11-Apr-2025 New long-term progression free survival data projections reinforce subcutaneous DARZALEX® (daratumumab) quadruplet therapy as a foundational standard of care for patients with newly diagnosed multiple myeloma Johnson & Johnson
11-Apr-2025 OncoZenge enters licensing agreement with Avernus Pharma for BupiZenge™ in the GCC Region OncoZenge
11-Apr-2025 OncoZenge receives milestone payment from Molteni OncoZenge
11-Apr-2025 EVERSANA Unveils EVERSANA ORCHESTRATE™ MLR, an AI-Powered Solution to Transform the Medical, Legal & Regulatory Process EVERSANA
11-Apr-2025 MEDICAL BOOST FOR YOUNG MEN AS NEW, HIGHLY ACCURATE EARLY DETECTION TESTICULAR CANCER TEST LAUNCHED IN UK EDX Medical
11-Apr-2025 Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE
11-Apr-2025 Gerresheimer: Bormioli Pharma boosts revenues and earnings Gerresheimer AG
10-Apr-2025 Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments Immunic AG
10-Apr-2025 SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations  SCHOTT Pharma AG & Co. KGaA
10-Apr-2025 Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors Galenica AG
10-Apr-2025 FamiCord AG significantly exceeds annual earnings guidance for 2024 on the basis of preliminary figures FamiCord AG
10-Apr-2025 Straumann Group shareholders approve all proposals Straumann Holding AG
10-Apr-2025 Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe SCHOTT Pharma AG & Co. KGaA
10-Apr-2025 Siegfried shareholders approve all proposals at Annual General Meeting 2025 Siegfried AG
10-Apr-2025 Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig Eckert & Ziegler SE
10-Apr-2025 Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use Viromed Medical AG
10-Apr-2025 Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies Cellistic
10-Apr-2025 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update CureVac
10-Apr-2025 Evotec SE to announce results for financial year 2024 on 17 April 2025 Evotec SE